Frequently Asked Questions
The market is segmented based on Global Veterinary-Animal Vaccines Market, By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Other Animal Vaccines), Disease (Porcine, Poultry, Livestock, Companion Animals, Aquaculture), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), Route of Administration (Oral, Parenteral, Topical), End-Use (Hospitals, Clinics) – Industry Trends and Forecast to 2030.
.
The Global Veterinaryanimal Vaccines Market size was valued at USD 10.69 USD Billion in 2022.
The Global Veterinaryanimal Vaccines Market is projected to grow at a CAGR of 6.9% during the forecast period of 2023 to 2030.
The major players operating in the market include
- Bayer AG
- Sanofi
- Pfizer
- GSK plc
- Merck & Co.
- Ceva
- Cargill ,orporated
- Boehringer Ingelheim International GmbH.
- Takeda Pharmaceutical Company Limited
- Zoetis
- Dechra Pharmaceuticals PLC
- Hester Biosciences Limited.
- Elanco
- Phibro Animal Health Corporation
- Indovax,
.
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
